0000000000261424

AUTHOR

Jens Gottlieb

showing 5 related works from this author

Lung Preservation With Perfadex or Celsior in Clinical Transplantation: A Retrospective Single-Center Analysis of Outcomes.

2015

BACKGROUND Despite improvement of lung preservation by the introduction of low-potassium dextran (LPD) solution, ischemia-reperfusion injury remains a major contributor to early post-lung transplant graft dysfunction and mortality. After favorable experimental data, Celsior solution was used in our clinical lung transplant program. Data were compared with our historic LPD cohort. METHODS Between January 2002 and January 2005, 209 consecutive lung transplantations were performed with LPD. These were compared to 208 transplants between February 2005 and September 2007 with Celsior. Endpoints included posttransplant PaO2/FiO2 ratio at different timepoints after intensive care unit (ICU) admiss…

AdultMalemedicine.medical_specialtyTime FactorsOrgan Preservation SolutionsBronchiolitis obliteransKaplan-Meier EstimateSingle CenterDisaccharidesDisease-Free Survivallaw.inventionElectrolytesGlutamateslawRisk FactorsGermanymedicineHumansHistidineMannitolCitratesProportional Hazards ModelsRetrospective StudiesTransplantationLungProportional hazards modelbusiness.industryRetrospective cohort studyOrgan PreservationLength of StayMiddle Agedmedicine.diseaseIntensive care unitGlutathioneRespiration ArtificialSurgeryTransplantationIntensive Care Unitsmedicine.anatomical_structureTreatment OutcomeCohortBronchiolitisFemalePrimary Graft DysfunctionbusinessLung TransplantationTransplantation
researchProduct

S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose

2013

Die idiopathische pulmonale Fibrose (IPF) ist eine schwerwiegende und in der Regel zum Tod fuhrende Erkrankung, die bisher nur unzureichend behandelt werden kann. Empfehlungen zur Diagnostik und Therapie wurden erstmals im ATS-ERS-Statement im Jahr 2000 publiziert 1 . Seither haben sich die diagnostischen Standards geandert und es liegen zahlreiche Therapiestudien zu diesem Krankheitsbild vor, die es erforderlich machten, die bestehenden Empfehlungen zu uberarbeiten und eine wissenschaftlich begrundete Leitlinie zu erstellen. Diese wurde von einer internationalen Expertengruppe in den Jahren 2006 – 2010 erarbeitet und publiziert 2 . Die folgenden Ausfuhrungen beinhalten eine Ubersetzung wes…

Pulmonary and Respiratory MedicineGynecologymedicine.medical_specialtybusiness.industryMedizinMedicineGuidelinebusiness
researchProduct

Evolving Risk Factors for Mortality after Lung Transplantation over the Last 10 Years: Insights from a Single-Centre Database

2016

s S233 218 (82%) patients received pooled platelet transfusion -median (IQR) 1(1-2) U. 209 (79%) and 129 (49%) patients received fresh frozen plasma (FFP) and cryoprecipitate with a median (IQR) of 3(2-4) and 0(0-0) U respectively. Conclusion: Rate and volume of transfusion of blood products compare favourably with centres performing surgery off CPB or on ECMO. Requirement for ECMO particularly for BTT, but also PGD is associated with high transfusion requirements.

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentSurgerySingle centresurgical procedures operativePlatelet transfusionCryoprecipitatemedicineLung transplantationSurgeryFresh frozen plasmaCardiology and Cardiovascular MedicinebusinessIntensive care medicineThe Journal of Heart and Lung Transplantation
researchProduct

Retrograde in situ versus antegrade pulmonary preservation in clinical lung transplantation: a single-centre experience.

2014

OBJECTIVE Experimental and clinical studies have indicated a beneficial effect of retrograde lung preservation on post-transplant results. Accordingly, we conducted a non-randomized trial. METHODS A total of 209 consecutive recipients transplanted with low-potassium dextrane (LPD)-preserved lungs were eligible for analysis. Antegrade lung preservation (AP) was performed in 173 patients and retrograde in situ perfusion (RP) in 36 patients using low-potassium dextrane solution in all cases. The prostacycline was added to preservation solution. RESULTS The main donor, graft and recipient characteristics did not differ significantly between groups. There was a beneficial trend toward improved o…

Pulmonary and Respiratory MedicineAdultGraft RejectionMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentOrgan Preservation SolutionsUrologyPrimary Graft DysfunctionBronchiolitis obliteransKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk AssessmentStatistics NonparametricCohort Studies03 medical and health sciences0302 clinical medicinemedicineLung transplantationHumansProportional Hazards ModelsRetrospective StudiesLungbusiness.industryIncidence (epidemiology)Graft SurvivalGeneral MedicineOxygenationOrgan PreservationMiddle Agedmedicine.diseaseSurvival AnalysisTissue DonorsTransplantationmedicine.anatomical_structureTreatment Outcome030228 respiratory systemCohortMultivariate AnalysisSurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesLung TransplantationEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Exceptional LAS Requests in Eurotransplant: Analysis of an 8-year Effort to Improve Lung Allocation for Precarious Patients

2020

PURPOSE: Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifically in case of primary pulmonary hypertension group 1 and 4; combined lung+non-renal transplantation; rare diseases; or extracorporeal support. Each eLAS proposal is evaluated by a LAS Review Board, consisting of ≥3 lung transplant experts, which subsequently declines or approves the eLAS request in consensus of ≥3 votes. In case of a lower than accepted score, predefined business rules to assign LAS percentiles are used. METHODS: A retrospective…

Pulmonary and Respiratory MedicineTransplantationPediatricsmedicine.medical_specialtyLungbusiness.industryAcceptance rateSciences bio-médicales et agricolesmedicine.diseaseGroup BObstructive lung diseaseTransplantationmedicine.anatomical_structuremedicineRetrospective analysisSurgeryRestrictive lung diseaseCardiology and Cardiovascular MedicinebusinessLung allocation score
researchProduct